Cargando…

N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition

Background: Vasculogenic mimicry (VM) is a functional microcirculation pattern formed by aggressive tumor cells. Thus far, no effective drugs have been developed to target VM. Glioblastoma (GBM) is the most malignant form of brain cancer and is a highly vascularized tumor. Vasculogenic mimicry repre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagano, Cristina, Navarra, Giovanna, Pastorino, Olga, Avilia, Giorgio, Coppola, Laura, Della Monica, Rosa, Chiariotti, Lorenzo, Florio, Tullio, Corsaro, Alessandro, Torelli, Giovanni, Caiazzo, Pasquale, Gazzerro, Patrizia, Bifulco, Maurizio, Laezza, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508824/ https://www.ncbi.nlm.nih.gov/pubmed/34638872 http://dx.doi.org/10.3390/ijms221910530

Ejemplares similares

N6-isopentenyladenosine induces cell death through necroptosis in human glioblastoma cells
por: Pagano, Cristina, et al.
Publicado: (2022)

N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma Cells
por: Pagano, Cristina, et al.
Publicado: (2022)

N(6)-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression
por: Navarra, Giovanna, et al.
Publicado: (2020)

N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil Targeting FBXW7 Tumor Suppressor
por: Fiore, Donatella, et al.
Publicado: (2019)

Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells
por: Pastorino, Olga, et al.
Publicado: (2019)

Vasculogenic mimicry
por: Pandiar, Deepak, et al.
Publicado: (2023)

Cannabinoids: Therapeutic Use in Clinical Practice
por: Pagano, Cristina, et al.
Publicado: (2022)

Cannabinoids in the Modulation of Oxidative Signaling
por: Pagano, Cristina, et al.
Publicado: (2023)

Relationship between the expression of ARHGAP25 and RhoA in non-small cell lung cancer and vasculogenic mimicry
por: Shi, Fan, et al.
Publicado: (2022)

The Endocannabinoid System: A Target for Cancer Treatment
por: Laezza, Chiara, et al.
Publicado: (2020)

Advanced research on vasculogenic mimicry in cancer
por: Qiao, Lili, et al.
Publicado: (2015)

Mechanisms of Vasculogenic Mimicry in Ovarian Cancer
por: Ayala-Domínguez, Lízbeth, et al.
Publicado: (2019)

An Overview of Vasculogenic Mimicry in Breast Cancer
por: Andonegui-Elguera, Marco A., et al.
Publicado: (2020)

Vasculogenic mimicry in carcinogenesis and clinical applications
por: Luo, Qingxi, et al.
Publicado: (2020)

Clinical significance of vasculogenic mimicry in human gliomas
por: Liu, Xiao-mei, et al.
Publicado: (2011)

Slug promoted vasculogenic mimicry in hepatocellular carcinoma
por: Sun, Dan, et al.
Publicado: (2013)

Vasculogenic mimicry in small cell lung cancer
por: Williamson, Stuart C., et al.
Publicado: (2016)

Structural and functional identification of vasculogenic mimicry in vitro
por: Racordon, Dusan, et al.
Publicado: (2017)

Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
por: López-Camarillo, César, et al.
Publicado: (2020)

Platelets disrupt vasculogenic mimicry by cancer cells
por: Martini, Carmela, et al.
Publicado: (2020)

Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
por: Wei, Xiaoxu, et al.
Publicado: (2021)

Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023)

Advance in vasculogenic mimicry in ovarian cancer (Review)
por: Tian, Xinyuan, et al.
Publicado: (2023)

Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling
por: Zhang, Ji-Gang, et al.
Publicado: (2020)

Vasculogenic mimicry: a novel target for glioma therapy
por: Chen, Yin-Sheng, et al.
Publicado: (2014)

The relationship between vasculogenic mimicry and epithelial‐mesenchymal transitions
por: Liu, Qiqi, et al.
Publicado: (2016)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Xiang, Tong, et al.
Publicado: (2018)

Vasculogenic Mimicry: Become an Endothelial Cell “But Not So Much”
por: Fernández-Cortés, Mónica, et al.
Publicado: (2019)

Fact or Fiction, It Is Time for a Verdict on Vasculogenic Mimicry?
por: Valdivia, Andrés, et al.
Publicado: (2019)

Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer
por: Lim, Dansaem, et al.
Publicado: (2020)

Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors
por: Hernández de la Cruz, Olga N., et al.
Publicado: (2020)

Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry
por: Zhang, Xue, et al.
Publicado: (2019)

Vasculogenic Mimicry Formation Predicts Tumor Progression in Oligodendroglioma
por: Xie, Jing, et al.
Publicado: (2021)

Tyrosinase suppresses vasculogenic mimicry in human melanoma cells
por: Kamo, Hiroki, et al.
Publicado: (2022)

Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers
por: Morales-Guadarrama, Gabriela, et al.
Publicado: (2021)

Vasculogenic mimicry structures in melanoma support the recruitment of monocytes
por: Tan, Lih Y., et al.
Publicado: (2022)

Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry
por: Andreucci, Elena, et al.
Publicado: (2022)

FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer
por: Recouvreux, Maria Sol, et al.
Publicado: (2022)

Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma
por: Zhang, Shiwu, et al.
Publicado: (2008)

Galunisertib inhibits glioma vasculogenic mimicry formation induced by astrocytes
por: Zhang, Chao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sfg4ma3j924015sogm7sq98il1